6-chloro-4-(cyclopropylethynyl)-8-hydroxy-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one,
8-hydroxy-efavirenz,
8-hydroxy-efavirenz-glucuronide,
8-hydroxyefavirenz,
8-Hydroxyefavirenz,
8-hydroxy efavirenz,
UNII-P8S49CKH6L,
CHEMBL1309,
P8S49CKH6L,
205754-33-2,
(4S)-6-chloro-4-(2-cyclopropylethynyl)-8-hydroxy-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one,
2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-, (4S)-,
2H-3,1-Benzoxazin-2-one,6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-,
8-OH efavirenz,
8-hydroxy EFV,
AC1LAGG7,
8-OH EFV,
AC1Q4I0Z,
(4s)-6-chloro-4-(cyclopropylethynyl)-8-hydroxy-4-(trifluoromethyl)-1,4-dihydro-2h-3,1-benzoxazin-2-one,
CTK4E4582,
(S)-6-Chloro-4-cyclopropylethynyl-8-hydroxy-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one,
ZINC6524414,
BDBM50097571,
AKOS030255837,
6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one,
Efavirenz metabolite,
rac 8-Hydroxy Efavirenz,
AIDS110291,
KST-1A2589,
AR-1A6099,
CID487643,
205754-32-1,
20677-77-4,